Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies

Article Properties
  • Language
    English
  • DOI (url)
  • Publication Date
    2024/04/16
  • Journal
  • Indian UGC (journal)
  • Refrences
    150
  • Hiroyuki Suzuki Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan ORCID (unauthenticated)
  • Kento Kannaka Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan ORCID (unauthenticated)
  • Tomoya Uehara Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan
Abstract
Cite
Suzuki, Hiroyuki, et al. “Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies”. Pharmaceuticals, vol. 17, no. 4, 2024, p. 508, https://doi.org/10.3390/ph17040508.
Suzuki, H., Kannaka, K., & Uehara, T. (2024). Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies. Pharmaceuticals, 17(4), 508. https://doi.org/10.3390/ph17040508
Suzuki H, Kannaka K, Uehara T. Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies. Pharmaceuticals. 2024;17(4):508.
Journal Categories
Medicine
Pharmacy and materia medica
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Refrences
Title Journal Journal Categories Citations Publication Date
Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides Chemical Reviews
  • Science: Chemistry: General. Including alchemy
  • Science: Chemistry
11 2023
Reduction of the Renal Radioactivity of 111In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes Journal of Medicinal Chemistry
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
4 2023
An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy Journal of Nuclear Medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
33 2022
Advancing Chelation Strategies for Large Metal Ions for Nuclear Medicine Applications Accounts of Chemical Research
  • Science: Chemistry: General. Including alchemy
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
21 2022
Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology

Journal for ImmunoTherapy of Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
23 2022